N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance

Alterations in the Nervous System and Gut Microbiota after β-Hemolytic Streptococcus Group A Infection—Characteristics and Diagnostic Criteria of PANDAS Recognition

(2020) Jacek Baj et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

White Matter in Schizophrenia Treatment Resistance

(2019) Peter Kochunov et al.   AMERICAN JOURNAL OF PSYCHIATRY

Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies

(2019) Andreas Schwarting et al.   ANNALS OF THE RHEUMATIC DISEASES

Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia

(2019) Jinghui Tong et al.   BRAIN BEHAVIOR AND IMMUNITY

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium

(2018) Theo G.M. van Erp et al.   BIOLOGICAL PSYCHIATRY

Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum

(2018) Luciana R. Frick et al.   BRAIN BEHAVIOR AND IMMUNITY

Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis

(2018) Gabriel Westman et al.   JOURNAL OF CLINICAL VIROLOGY

Phosphodiesterase 2A Inhibitor TAK-915 Ameliorates Cognitive Impairments and Social Withdrawal inN-Methyl-d-Aspartate Receptor Antagonist–Induced Rat Models of Schizophrenia

(2018) Masato Nakashima et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Toxoplasma gondii infection

(2018) Xiaotang Cai et al.   MEDICINE

Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction

(2018) Kazuhito Nakao et al.   SCHIZOPHRENIA BULLETIN

Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis

(2018) J. Jézéquel et al.   TRENDS IN NEUROSCIENCES

Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: a proof-of-concept study

(2018) Natasza D. Orlov et al.   Translational Psychiatry

Superficial white matter damage in anti-NMDA receptor encephalitis

(2017) Owen Robert Phillips et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia

(2017) Chin-Chuen Lin et al.   PLoS One

Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia

(2017) G Kannan et al.   Translational Psychiatry

From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link

(2017) Guglielmo Lucchese   Frontiers in Psychiatry

Structural alterations of the superior temporal gyrus in schizophrenia: Detailed subregional differences

(2016) K. Ohi et al.   EUROPEAN PSYCHIATRY

The molecular physiology of the axo-myelinic synapse

(2016) Ileana Micu et al.   EXPERIMENTAL NEUROLOGY

Anti-Inflammatory Therapy and Immunotherapy Were Partially Effective in a Patient With Anti–N-Methyl-D-Aspartate Receptor Antibodies and a Special Subgroup of Treatment-Resistant Schizophrenia

(2016) Mayuko Senda et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii

(2016) Geetha Kannan et al.   NEUROBIOLOGY OF DISEASE

Ionotropic glutamate receptor expression in human white matter

(2016) Pia Crone Christensen et al.   NEUROSCIENCE LETTERS

Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies

(2016) Takahiro Ikura et al.   NEUROSCIENCE LETTERS

Long-term potentiation and the role of N -methyl- d -aspartate receptors

(2015) Arturas Volianskis et al.   BRAIN RESEARCH

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis

(2015) Katherine Beck et al.   BRITISH JOURNAL OF PSYCHIATRY

Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome

(2015) Tetsuhiro Fukuyama et al.   EPILEPSY RESEARCH

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia

(2015) M. E. Goldstein et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive

(2015) Elias Mouchlianitis et al.   SCHIZOPHRENIA BULLETIN

GLUTAMATE RECEPTOR ANTIBODIES IN NEUROLOGICAL DISEASES: Anti-AMPA-GluR3 antibodies, Anti-NMDA-NR1 antibodies, Anti-NMDA-NR2A/B antibodies, Anti-mGluR1 antibodies or Anti-mGluR5 antibodies are present in subpopulations of patients with either: Epilepsy, Encephalitis, Cerebellar Ataxia, Systemic Lupus Erythematosus (SLE) and Neuropsychiatric SLE, Sjogren’s syndrome, Schizophrenia, Mania or Stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor’s expression, impair glutamate-induced signaling and function, activate Blood Brain Barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and Ataxia in animal models, and can be removed or silenced in some patients by immunotherapy

(2014) Mia Levite   JOURNAL OF NEURAL TRANSMISSION

Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report

(2014) G. J. Gilbert et al.   NEUROLOGY

Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis

(2014) S. Veerman et al.   PHARMACOPSYCHIATRY

Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder

(2014) Daniel M. Pearlman et al.   SCHIZOPHRENIA RESEARCH

Phonetic Feature Encoding in Human Superior Temporal Gyrus

(2014) N. Mesgarani et al.   SCIENCE

Neuregulin and BDNF Induce a Switch to NMDA Receptor-Dependent Myelination by Oligodendrocytes

(2014) Iben Lundgaard et al.   PLOS BIOLOGY

Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function

(2013) Arsime Demjaha et al.   BIOLOGICAL PSYCHIATRY

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity

(2013) C Hammer et al.   MOLECULAR PSYCHIATRY

Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: A pilot project of the ENIGMA–DTI working group

(2013) Neda Jahanshad et al.   NEUROIMAGE

Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia

(2013) Johann Steiner et al.   JAMA Psychiatry

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment

(2012) Oliver D. Howes et al.   ARCHIVES OF GENERAL PSYCHIATRY

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

(2012) Ko Tsutsui et al.   BMC Psychiatry

Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes

(2012) Shunske Tanahashi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Addressing Nonresponse in Schizophrenia

(2012) John M. Kane   JOURNAL OF CLINICAL PSYCHIATRY

Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt–Jakob disease patients

(2012) Koji Fujita et al.   JOURNAL OF NEUROIMMUNOLOGY

How does the corpus callosum mediate interhemispheric transfer? A review

(2011) Lisette J. van der Knaap et al.   BEHAVIOURAL BRAIN RESEARCH

Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis

(2010) E. G. Hughes et al.   JOURNAL OF NEUROSCIENCE

Glutamate Receptor Ion Channels: Structure, Regulation, and Function

(2010) S. F. Traynelis et al.   PHARMACOLOGICAL REVIEWS

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

(2008) Josep Dalmau et al.   LANCET NEUROLOGY

Fronto-temporal brain systems supporting spoken language comprehension

(2007) L. K Tyler et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES